These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 705690

  • 21. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S.
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [Abstract] [Full Text] [Related]

  • 22. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
    Preissner KT, Müller-Berghaus G.
    Eur J Biochem; 1986 May 02; 156(3):645-50. PubMed ID: 3699029
    [Abstract] [Full Text] [Related]

  • 23. The interaction of heparin with plasma proteins. Demonstration of different binding sites for antithrombin III complexes and antithrombin III.
    McKay EJ, Laurell CB.
    J Lab Clin Med; 1980 Jan 02; 95(1):69-80. PubMed ID: 7350242
    [Abstract] [Full Text] [Related]

  • 24. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A, Krachmalnicoff A, Mannucci PM.
    Thromb Haemost; 1986 Dec 15; 56(3):349-52. PubMed ID: 3563966
    [Abstract] [Full Text] [Related]

  • 25. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
    Lane DA, Flynn A, Ireland H, Erdjument H, Samson D, Howarth D, Thompson E.
    Br J Haematol; 1987 Apr 15; 65(4):451-6. PubMed ID: 3580302
    [Abstract] [Full Text] [Related]

  • 26. [Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)].
    Aiach M, Fiessinger JN, Andreux JP, Beuvin J, Housset E, Leclerc M.
    Pathol Biol (Paris); 1977 Dec 15; 25 Suppl():35-41. PubMed ID: 353657
    [Abstract] [Full Text] [Related]

  • 27. The inhibition of high and low molecular weight urokinase in plasma.
    Murano G, Aronson D, Williams L, Brown L.
    Blood; 1980 Mar 15; 55(3):430-6. PubMed ID: 6444529
    [Abstract] [Full Text] [Related]

  • 28. Inhibitors of plasminogen activation in human blood.
    Beattie AG, Ogston D, Bennett B, Douglas AS.
    Br J Haematol; 1976 Jan 15; 32(1):135-43. PubMed ID: 1259923
    [Abstract] [Full Text] [Related]

  • 29. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.
    Clemmensen I, Petersen LC, Kluft C.
    Eur J Biochem; 1986 Apr 15; 156(2):327-33. PubMed ID: 3009181
    [Abstract] [Full Text] [Related]

  • 30. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.
    J Clin Invest; 1986 Mar 15; 77(3):887-93. PubMed ID: 3512602
    [Abstract] [Full Text] [Related]

  • 31. Complex-formation and inhibition of urokinase by blood plasma proteins.
    Waller EK, Schleuning WD, Reich E.
    Biochem J; 1983 Oct 01; 215(1):123-31. PubMed ID: 6194790
    [Abstract] [Full Text] [Related]

  • 32. Purification and characterization of guinea pig antithrombin III.
    Clement LT.
    Prep Biochem; 1983 Oct 01; 13(1):1-20. PubMed ID: 6856582
    [Abstract] [Full Text] [Related]

  • 33. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
    Sudol M, Reich E.
    Biochem J; 1984 May 01; 219(3):971-8. PubMed ID: 6430276
    [Abstract] [Full Text] [Related]

  • 34. Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III).
    D'Souza S, Ananthakrishnan R.
    Aust J Exp Biol Med Sci; 1979 Jun 01; 57(3):245-50. PubMed ID: 316999
    [Abstract] [Full Text] [Related]

  • 35. Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.
    Koide T, Takahashi K, Odani S, Ono T, Sakuragawa N.
    Thromb Res; 1983 Jul 15; 31(2):319-28. PubMed ID: 6636046
    [Abstract] [Full Text] [Related]

  • 36. [Study of serum level of antithrombin-III antigen, antithrombin activity, and its ratio of AT-III-heparin complex formation in maintenance hemodialysis patients].
    Yoshida K, Saka M, Kaneko Y, Kubota K, Hirao Y, Okajima E, Ishida M, Kihouin K, Motomiya Y.
    Nihon Jinzo Gakkai Shi; 1989 Nov 15; 31(11):1171-7. PubMed ID: 2625740
    [Abstract] [Full Text] [Related]

  • 37. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
    Collen D.
    Eur J Biochem; 1976 Oct 01; 69(1):209-16. PubMed ID: 136345
    [Abstract] [Full Text] [Related]

  • 38. Isolation and partial characterization of two distinct types of antithrombin III from rabbit.
    Carlson TH, Atencio AC.
    Thromb Res; 1982 Jul 01; 27(1):23-34. PubMed ID: 7123512
    [Abstract] [Full Text] [Related]

  • 39. Studies of the heterogeneity of antithrombin III concentrates.
    Barrowcliffe TW, Eggleton CA, Mahmoud M.
    Br J Haematol; 1983 Sep 01; 55(1):37-46. PubMed ID: 6882687
    [Abstract] [Full Text] [Related]

  • 40. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.
    Wolf M, Boyer C, Tripodi A, Meyer D, Larrieu MJ, Mannucci PM.
    Blood; 1985 Feb 01; 65(2):496-500. PubMed ID: 3967090
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.